| 000 | 04169nam a22004575i 4500 | ||
|---|---|---|---|
| 999 |
_c381909 _d381909 _x1 |
||
| 001 | 381909 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102121940.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 220910s2022 si | s |||| 0|eng d | ||
| 020 | _a9789811916229 | ||
| 024 | 7 |
_a10.1007/978-981-19-1622-9 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRA650.7.J3 _b2022 EB |
|
| 245 | 0 | 0 |
_aEpidemiologic Research on Real-World Medical Data in Japan : _bVolume 2 _cedited by Naoki Nakashima |
| 250 | _aFirst edition 2022 | ||
| 264 | 1 |
_aSingapore _bSpringer Nature Singapore _c2022 |
|
| 300 |
_a1 recurso en línea (XXIX, 120 páginas) _b29 ilustraciones, 25 ilustraciones a color |
||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_aarchivo de texto _bPDF |
||
| 490 | 0 |
_aSpringerBriefs for Data Scientists and Innovators _x2520-1921 ; _v2 |
|
| 505 | 0 | _aPart 1: Clinical Pathway -- Chapter 1. Real World Medical Data Clinical Pathway in Japan -- Chapter 2. Medical process analysis by using all-variance type outcome-oriented electronic clinical pathway data -Exploratory extracting critical indicator -- Chapter 3. Information and Data standard development for Clinical Pathways -- Part 2: Standard Code Mapping and Data Quality -- Chapter 4. Japan Laboratory Code (JLAC) 10 -- Chapter 5. ICD-10 and ICD-11 in Japan -- Chapter 6. Standard codes for prescribing drugs use multiple code systems depending on their purpose -- Chapter 7. Data Quality Governance Experience at the MID-NET Project -- Part 3: Phenotyping -- Chapter 8. Phenotyping in Japan -- Chapter 9. Phenotyping of Administrative Claims Data -- Chapter 10. Phenotyping study using MID-NET database -- Chapter 11. Integration of phenotyping algorithms in Japan -- Part 4: Data Analysis on Real World Data -- Chapter 12. Analysis on Real-World Data: An Overview -- Chapter 13. Problems in Japanese real-world medical data analyses -- Part 5: Ethical Issues of Data Secondary Use in Japan -- Chapter 14. Ethical, Legal, and Social Issues Pertaining to the Use of Real-world Health Data in Japan -- Chapter 15. The Next-Generation Medical Infrastructure Law. | |
| 520 | _aThis book analyzes the development of medical big data projects in Japan. Japan is experiencing unprecedented population aging, and labor productivity has decreased accordingly. Big data analysis of the Japanese medical real-world database (RWD) has the potential to tackle this issue. To allow readers to gain an understanding of Japanese medical big data analysis, the book discusses the original Japanese system that generates medical RWDs in the hospital medical records system, the nationwide standardized health checkup system, and the public medical insurance system in Japan. After introducing four major big data projects in the healthcare-medical field in Japan, the book explains the importance of creating information standards to maintain data quality and to analyze medical big data. It enables readers to analyze which standards are installed in which RWDs, how the standards are maintained, and which issues are prevalent in Japan. This book also describes the ethical processes involved in big data projects involving medical RWDs in Japan. | ||
| 988 | _aSpringer_Medicine_2022 | ||
| 650 | 7 |
_2embne _9138405 _aEpidemiología _zJapón |
|
| 650 | 7 |
_2embne _9421154 _aInformática médica _zJapón |
|
| 700 | 1 |
_aNakashima, Naoki _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811916212 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811916236 |
| 830 | 0 |
_aSpringerBriefs for Data Scientists and Innovators, _x2520-1921 ; _v2 |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-19-1622-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b09/2022 _dz _eIG _zSI |
||